About CJC-1295
CJC-1295 is a synthetic growth hormone-releasing hormone analogue developed to extend the activity of GHRH-related signalling. Research describes CJC-1295 as a long-acting GHRH analogue studied for its pharmacokinetic and pharmacodynamic effects on growth hormone and IGF-1 secretion. It has also been described as a 30-amino-acid peptide-based compound in detection and screening research, making it suitable to describe as a GHRF-family research peptide.
- 5mg vial
- Lyophilised powder format
- Clear product and storage information
- Third-party tested where applicable
- Research use only-
Reviews
There are no reviews yet